Table I.

Clinical characteristics of study subjects

Patient	Disease Stage	Gender	Age (years)	Race	Blood CD4+ T Cell Count (cells/μl)	Plasma HIV-1 RNA Level (copies/ml)
1476	Uninfected	Female	28	Hispanic	704	Undetectable
1472	Uninfected	Female	52	Caucasian	837	Undetectable
1442	Uninfected	Female	45	Caucasian	485	Undetectable
1452	Uninfected	Male	40	Hispanic	742	Undetectable
1467	Uninfected	Male	26	Caucasian	326	Undetectable
1324	Acute	Male	41	Caucasian	494	14,696
1430	Acute	Male	26	Caucasian	683	3,610
1458	Acute	Male	51	Caucasian	400	439,000
1329	Acute	Male	59	Caucasian	370	484,694
1389	Acute	Male	32	Caucasian	824	32,173
1449	Acute	Male	30	Caucasian	333	>100,000
1435	Acute	Male	42	Caucasian	410	>100,000
1391	Acute	Male	37	African American	414	24,718
1455	Acute	Male	23	African American	209	19,400
1463	Asympta	Male	23	African American	259	27,200
1335	Asympt	Male	32	Caucasian	400	15,284
1431	Asympt	Male	34	Caucasian	333	71,200
1464	Asympt	Male	34	Caucasian	202	122,000
1456	Asympt	Male	49	Caucasian	478	174,000
1408	Asympt	Male	39	Caucasian	685	20,014
1436	Asympt	Male	63	Caucasian	248	46,400
1407	Asympt	Male	35	Caucasian	372	31,922
1459	Asympt	Male	36	Caucasian	286	>100,000
1438	AIDS	Male	49	Caucasian	147	4,960
1406	AIDS	Male	45	African American	188	10,684
1462	AIDS	Male	43	Caucasian	81	35,000
1327	AIDS	Female	40	African American	112	12,046

Note. Undetectable, assay limit of detection (50 copies/ml).

^aAsympt, Asymptomatic stage.